Quebec Opioid Lawsuit Targets Eight Pharma Firms

A massive class-action lawsuit is unfolding in Quebec targeting eight major pharmaceutical companies, accusing them of knowingly downplaying the addictive risks of their opioid painkillers—leading thousands to addiction after being prescribed them for legitimate injuries. Lawyers are reaching out to vulnerable plaintiffs, including those who are homeless, incarcerated, or in long-term care, through pharmacies, jails, and community centers like Méta d’Âme in Montreal. With around 13,000 Quebecers treated for opioid addiction, the case seeks compensation for victims, including lead plaintiff Jean-François Bourassa, who described his decade-long struggle as a “living hell.” Though defendants deny wrongdoing and argue the lawsuit includes drugs some plaintiffs never took, a court has rejected their bid to block the case. Lawyers are now considering extending the July 31 deadline by six months to ensure more victims can join. This Quebec-specific case, separate from national lawsuits, underscores the urgent need for justice and recovery in the opioid crisis. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/dba6296d110f90a7